Ignite Creation Date:
2024-05-06 @ 8:36 AM
Last Modification Date:
2024-10-26 @ 12:02 PM
Study NCT ID:
NCT02775006
Status:
TERMINATED
Last Update Posted:
2019-04-30
First Post:
2016-04-12
Brief Title:
Docetaxel Versus Intercalated Erlotinib-docetaxel in Patients With Relapsed EGFR Wild Type ALK Negative Non Squamous Cell Carcinoma
Sponsor:
Organization:
The Netherlands Cancer Institute